Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study

The aim of this Phase I clinical trial was to assess the feasibility and safety of capecitabine-based preoperative chemoradiotherapy (CRT) combined with bevacizumab and to determine the optimal capecitabine dose for Japanese patients with locally advanced rectal cancer. Patients with cT3/T4 rectal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miki, Yoshitaka, Maeda, Kiyoshi, Hosono, Masako, Nagahara, Hisashi, Hirakawa, Kosei, Shimatani, Yasuhiko, Tsutsumi, Shinichi, Miki, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229928/
https://www.ncbi.nlm.nih.gov/pubmed/25129557
http://dx.doi.org/10.1093/jrr/rru063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229928/
https://www.ncbi.nlm.nih.gov/pubmed/25129557
http://dx.doi.org/10.1093/jrr/rru063

Ejemplares similares